Related Experiment Videos
Cost and cost-effectiveness studies in heart failure research
William S Weintraub1, Jason Cole, Joseph F Tooley
1Division of Cardiology, Emory University School of Medicine, Atlanta, Ga, USA. wweintr@emory.edu
American Heart Journal
|March 30, 2002
Summary
Economic studies are crucial for making informed decisions about heart failure treatments. Reviewing cost-effectiveness in heart failure research helps optimize resource allocation for better patient outcomes.
Area of Science:
- Cardiology
- Health Economics
Background:
- Heart failure is a significant cause of death, disability, and resource utilization in the US.
- Prevalence is 4.6 million, with 550,000 new cases and 957,000 hospitalizations annually.
Purpose of the Study:
- To review methods for evaluating cost and outcome in heart failure research.
- To assess economic and cost-effectiveness studies within heart failure clinical trials.
Main Methods:
- Review of economic and cost-effectiveness studies.
- Analysis of therapeutic areas including digoxin, ACE inhibitors, beta blockers, disease management, and transplantation.
Main Results:
- Methods for cost-outcome evaluation and comparison are discussed.
- Economic studies in specific heart failure therapies are examined.
Conclusions:
- Economic studies aid rational decision-making amid resource constraints.
- Improved economic research in heart failure supports informed societal choices.